Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / PCRX - Pacira Biosciences posts wider-than-expected loss


PCRX - Pacira Biosciences posts wider-than-expected loss

  • Pacira BioSciences ( NASDAQ: PCRX ) posted wider-than-expected quarterly loss, as costs increased.
  • Revenue rose 31.1% Y/Y to $167.5M in-line with estimates. Q3 GAAP EPS of -$0.02 misses by $0.39.
  • Non-GAAP net income was $29.9 million, or $0.64 per share in the third quarter of 2022, compared to $32.5 million, or $0.72 per share, in the third quarter of 2021.
  • Exparel net product sales were $132.6 million in the third quarter of 2022, versus the $121.9 million, a year earlier.

For further details see:

Pacira Biosciences posts wider-than-expected loss
Stock Information

Company Name: Pacira BioSciences Inc.
Stock Symbol: PCRX
Market: NASDAQ
Website: pacira.com

Menu

PCRX PCRX Quote PCRX Short PCRX News PCRX Articles PCRX Message Board
Get PCRX Alerts

News, Short Squeeze, Breakout and More Instantly...